Society of Family Planning signs on in support of Protecting Cures Act of 2020

On April 1st, the Society of Family Planning joined our colleagues at the American Society for Reproductive Medicine, International Society for Stem Cell Research, Medical Students for Choice, and the Society for Maternal-Fetal Medicine among many others in signaling our support for the Protecting Cures Act of 2020 (H.R. 6417). Restrictions imposed in 2019 on the use of fetal tissue in biomedical research have had a stifling effect on the ability of experts to innovate, which is needed now more than ever. This new legislation would remove those restrictions and enact guardrails to protect biomedical research involving fetal tissue moving forward. We hope our government leaders will trust the science and the leaders in the scientific community, acting to remove barriers for researchers working to find a cure or treatment to end the COVID-19 pandemic.

We are delighted to announce the 2023 SFP NIH Navigation Cohort, an NIH proposal development program led by Vanessa Dalton, [...] READ MORE
In an effort to support and elevate the knowledge of individuals working at community-based organizations, with a focus on lifting [...] READ MORE
Join us in listening in on our new podcast series, Source for Science. Our first episode, Clinician perspectives on self-managed abortion features Nisha Verma, [...] READ MORE
The Society of Family Planning has released an interim clinical recommendation for self-managed abortion. Increased interest and attention directed towards [...] READ MORE
The Society of Family Planning Research Fund is seeking participants to join a time-limited learning community for researchers focused on [...] READ MORE
The Society of Family Planning Research Fund is committed to supporting an inclusive, multidisciplinary, skilled, and well-connected community of scholars [...] READ MORE
In an effort to document the impact of changes to the US legal abortion landscape on people whose access to [...] READ MORE
We are excited to share that 28 Society of Family Planning members are listed as key authors on our fifth-annual [...] READ MORE
Together, we have faced unprecedented challenges this year. And we, at the Society of Family Planning, have never been more [...] READ MORE
Today, we have learned that the US Food and Drug Administration’s review of the risk evaluation and mitigation strategy (REMS) [...] READ MORE
The Society now has even more ways to support your professional development and continuing education needs through our Continuing Education [...] READ MORE